Correlation Between Acumen Pharmaceuticals and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Bolt Biotherapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Bolt Biotherapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Bolt Biotherapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Acumen and Bolt is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Bolt Biotherapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Bolt Biotherapeutics. In addition to that, Acumen Pharmaceuticals is 1.5 times more volatile than Bolt Biotherapeutics. It trades about -0.05 of its total potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.05 per unit of volatility. If you would invest 67.00 in Bolt Biotherapeutics on October 7, 2024 and sell it today you would lose (8.00) from holding Bolt Biotherapeutics or give up 11.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Bolt Biotherapeutics
Performance |
Timeline |
Acumen Pharmaceuticals |
Bolt Biotherapeutics |
Acumen Pharmaceuticals and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Bolt Biotherapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |